Just a moment...
We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic
• Quick overview summary answering your query with references
• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced
• Includes everything in Basic
• Detailed report covering:
- Overview Summary
- Governing Provisions [Acts, Notifications, Circulars]
- Relevant Case Laws
- Tariff / Classification / HSN
- Expert views from TaxTMI
- Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.
Help Us Improve - by giving the rating with each AI Result:
Powered by Weblekha - Building Scalable Websites
Press 'Enter' to add multiple search terms. Rules for Better Search
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
The HC held that the product manufactured under a valid drug licence is classifiable as a drug/medicine under Entry 19-A, Part II, Schedule II of the MPVAT Act, and not as a cosmetic/beauty product. The HC quashed the impugned orders of the Commercial Tax Appellate Board and the Commercial Tax Board that had reclassified the product under other Schedule entries, answered the legal questions in favour of the appellant, and directed that the appellant is not liable to pay interest under Section 18(1)(a) of the MPVAT Act. Both VAT appeals were allowed and the appeals disposed.